Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance
Abstract Small cell lung cancer (SCLC) represents 15% of lung cancers and is characterized by early dissemination, development of chemoresistance and a poor prognosis. A host of diverse drugs failed invariably and its mechanisms of global chemoresistance have not been characterized so far. SCLC repr...
Guardado en:
Autores principales: | Lukas Klameth, Barbara Rath, Maximilian Hochmaier, Doris Moser, Marlene Redl, Felicitas Mungenast, Katharina Gelles, Ernst Ulsperger, Robert Zeillinger, Gerhard Hamilton |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2cf85fb0b7042ae8e2904ae222c0bb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Sajad Dar, et al.
Publicado: (2017) -
The role of peroxiredoxin II in chemoresistance of breast cancer cells
por: Wang T, et al.
Publicado: (2014) -
Markers of tumor-initiating cells predict chemoresistance in breast cancer.
por: Chang Gong, et al.
Publicado: (2010) -
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
por: Eva Obermayr, et al.
Publicado: (2021) -
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
por: Orza A, et al.
Publicado: (2013)